| Literature DB >> 28222680 |
Weiwei Xing1, Xinling Yu2, Jingtao Feng2, Kui Sun1, Wenliang Fu1, Yuanyuan Wang1, Minji Zou1, Wenrong Xia1, Zhihong Luo2, Hongbin He2, Yuesheng Li3, Donggang Xu4.
Abstract
BACKGROUND: Current diagnostic methods for Schistosoma japonicum infection are insensitive for low-density infections. Therefore, a new diagnostic assay based on recombinase polymerase amplification (RPA) technology was established and assessed for field applification.Entities:
Keywords: Diagnosis; Field evaluation; Recombinase polymerase amplification; Schistosoma japonicum
Mesh:
Substances:
Year: 2017 PMID: 28222680 PMCID: PMC5320755 DOI: 10.1186/s12879-017-2182-6
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
RPA primers and probe designed in this study
| Name | Sequence |
|---|---|
| S. | CCAAGTCTCAGTGAAGTTGTGAAGGCTAT |
| S. | GTTAGTGTTCGAGACCAGTCAGATGGGATT |
| S. | CTTAAAGCGAGGGAGAGCGGCAGGACCAGA |
FP forward primer, RP reverse primers, P probe, dT-FAM thymidine nucleotide carrying fluorescein, THF tetrahydrofuran spacer, dT-BHQ1 thymidine nucleotide carrying black hole quencher
Fig 1Analytical sensitivity of real-time RPA and real-time PCR for Schistosoma japonicum detection. Fluorescence development via real-time detection using a dilution range of 9 pg/μL–0.9 fg/μL of the S. japonicum genomic DNA. a Real-time RPA: 9 pg/μL, represented by the red line; 900 fg/μL, green; 90 fg/μL, pink; 9 fg/μL, cyan; 0.9 fg/μL, blue; negative control, black. b Real-time PCR: 9 pg/μL represented by the red line; 900 fg/μL, orange; 90 fg/μL, light green; 9 fg/μL, green; 0.9 fg/μL, cyan; negative control, pink
Fig 2The specificity of Schistosoma japonicum RPA. S. japonicum is represented by the blue line; S. mansoni, black; S. sinensium, green; S. haematobium, pink
Analysis of diagnostic validity of RPA
| Subjects | Investigated | RPA-positive |
|---|---|---|
| Controls (negative by KK method) | 30 | 0 (0%) |
| Cases (positive by KK method) | 30 | 30 (100%) |
Fig 3Agreement between RPA, Kato-Katz thick smear and MHT for stool-based diagnosis of Schistosoma japonicum infections. Values indicate the number of positive samples in each group
Estimation of diagnostic validity of RPA, IHA and ELISA
| Methods | TRUE positive | FALSE negative | TRUE negative | FALSE positive | Sensitivity (%, 95% CIa) | Specificity (%, 95% CIa) | PPV% (95% CIa) | NPV% (95% CIa) |
|---|---|---|---|---|---|---|---|---|
| RPA | 61 | 0 | 134 | 5 | 100% (100) | 96.40% (99.32–99.54) | 92.41% (86.06–98.83) | 100% (100) |
| IHA | 49 | 12 | 116 | 23 | 80.32% (70.37-90.45) | 83.45% (77.22-89.67) | 68.06% (57.37-78.82) | 90.67% (85.64-95.72) |
| ELISA | 52 | 9 | 130 | 9 | 85.24% (76.34-94.15) | 93.52% (89.44-97.61) | 85.37% (76.34-94.18) | 93.51% (89.45-97.67) |
a Exact 95% confidence intervals (CIs)
Agreement statistics were calculated for RPA, IHA and ELISA with stool-based tests
| Diagnostic test | Degree of agreement - Kappa value | 95% CIa |
|
|---|---|---|---|
| RPA vs. golden standard | 0.95 | 89– 99 | <0.001 |
| IHA vs. golden standard | 0.61 | 49– 72 | <0.001 |
| ELISA vs. golden standard | 0.78 | 69– 88 | <0.001 |
a Exact 95% confidence intervals (CIs)